H.R.5381 - International Pharmaceutical Transparency Act of 2019116th Congress (2019-2020)
|Sponsor:||Rep. DesJarlais, Scott [R-TN-4] (Introduced 12/10/2019)|
|Committees:||House - Energy and Commerce|
|Latest Action:||House - 12/11/2019 Referred to the Subcommittee on Health. (All Actions)|
This bill has the status Introduced
Here are the steps for Status of Legislation:
Summary: H.R.5381 — 116th Congress (2019-2020)All Information (Except Text)
With the start of a new Congress, summaries from prior Congresses may be delayed or abbreviated.